NASDAQ:ADPT Adaptive Biotechnologies Q3 2026 Earnings Date & Estimates $24.41 -0.92 (-3.63%) Closing price 04:00 PM EasternExtended Trading$24.56 +0.15 (+0.62%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Adaptive Biotechnologies is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Adaptive Biotechnologies in Q3 2026Adaptive Biotechnologies is expected to post earnings of -$0.0932 per share on revenue of $71.57 million. In the same quarter a year earlier Adaptive Biotechnologies reported -$0.15 per share on revenue of $93.97 million. Adaptive Biotechnologies last reported on July 29, 2026, posting -$0.25 per share and missing the -$0.1336 consensus estimate. Adaptive Biotechnologies has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.0932Expected Revenue$71.57 millionPrior-Year EPS-$0.15Prior-Year Revenue$93.97 millionExpected Revenue Growth-23.8%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.25 (Missed by -$0.1164)Last Quarter Revenue$71.55 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Adaptive Biotechnologies Q3 2026 Earnings FAQ When does Adaptive Biotechnologies report Q3 2026 earnings? Adaptive Biotechnologies (NASDAQ:ADPT) is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Adaptive Biotechnologies' Q3 2026 earnings call? Adaptive Biotechnologies' Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Adaptive Biotechnologies? Analysts expect Adaptive Biotechnologies to post earnings of -$0.0932 per share for Q3 2026. How much revenue is Adaptive Biotechnologies expected to report? The consensus revenue estimate for Adaptive Biotechnologies is $71.57 million for Q3 2026. Adaptive Biotechnologies Earnings HeadlinesAnalysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), Stoke Therapeutics (STOK) and Tango Therapeutics (TNGX)October 15, 2026 | theglobeandmail.comAdaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026October 14, 2026 | globenewswire.comYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strategy guide, titled How To Turn 100 Into 1000 Gains, before it moves behind a paywall. The guide walks through options trading concepts the team uses in its own research and education materials. Once the paywall goes up, free access ends for good.October 22 at 1:00 AM | TradeWins (Ad)Adaptive Biotechnologies Corporation (ADPT) - What Are Analysts Thinking About This Stock?October 12, 2026 | americanbankingnews.comAdaptive Biotechnologies (ADPT) Stock Sees Modest Fair Value Lift On MRD OptimismOctober 8, 2026 | finance.yahoo.comAdaptive Biotechnologies Insider Sold Shares Worth $1,014,329, According to a Recent SEC FilingOctober 6, 2026 | finance.yahoo.comSee More Adaptive Biotechnologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Adaptive Biotechnologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adaptive Biotechnologies and other key companies, straight to your email. Email Address About Adaptive BiotechnologiesAdaptive Biotechnologies (NASDAQ:ADPT) (NASDAQ: ADPT) is a biotechnology company focused on using the genetics of the adaptive immune system to develop diagnostic and research tools. Based in Seattle, Washington, the company analyzes immune-cell receptors to help identify and measure disease, support drug development and improve understanding of immune responses. Adaptive’s products include clonoSEQ, a clinical assay used to detect and monitor measurable residual disease in certain blood cancers, including multiple myeloma, acute lymphoblastic leukemia and chronic lymphocytic leukemia. The company also offers research services and platforms, including ImmunoSEQ, which enables researchers and biopharmaceutical companies to profile T-cell and B-cell receptors for applications in immunology, oncology, infectious disease and therapeutic development. Adaptive was founded in 2009 by brothers Chad Robins and Harlan Robins. Its services are used by healthcare providers, academic and medical researchers, pharmaceutical and biotechnology companies, and patients through clinical testing programs. Chad Robins serves as the company’s co-founder and chief executive officer.View Adaptive Biotechnologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Texas Paused Data Center Hookups—2 Power Stocks Are Waiting on the VerdictIs Texas Instruments Setting Up for Its Next Big Breakout?Lam Research's Earnings Beat Wasn't the Real Story—Its 2027 Outlook WasTesla’s Flying-Car Hype Hits an Earnings Reality CheckMeta Bounces Back in Q3, But the Bigger Test Comes in 2027Cologuard Is Working—So Why Isn’t Abbott Stock?Pegasystems' Q3 Miss Exposed the Problem Standing Between AI and Cash Flow Upcoming Earnings ENI (10/23/2026)SLB (10/23/2026)American Express (10/23/2026)Infosys (10/23/2026)Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
